ITCI
Prudential Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,030
| Closed | -$545K | – | 2534 |
|
|
2025
Q1 | $545K | Buy |
6,030
+1,740
| +41% | +$157K | ﹤0.01% | 1802 |
|
|
2024
Q4 | $358K | Sell |
4,290
-22,193
| -84% | -$1.85M | ﹤0.01% | 1942 |
|
|
2024
Q3 | $1.94M | Sell |
26,483
-94,518
| -78% | -$6.92M | ﹤0.01% | 1516 |
|
|
2024
Q2 | $8.29M | Sell |
121,001
-44,827
| -27% | -$3.07M | 0.01% | 724 |
|
|
2024
Q1 | $11.5M | Buy |
165,828
+83,817
| +102% | +$5.8M | 0.02% | 633 |
|
|
2023
Q4 | $5.87M | Buy |
82,011
+54,917
| +203% | +$3.93M | 0.01% | 858 |
|
|
2023
Q3 | $1.44M | Sell |
27,094
-77,940
| -74% | -$4.13M | ﹤0.01% | 1563 |
|
|
2023
Q2 | $6.65M | Buy |
105,034
+14,103
| +16% | +$893K | 0.01% | 784 |
|
|
2023
Q1 | $5.02M | Buy |
90,931
+22,041
| +32% | +$1.22M | 0.01% | 871 |
|
|
2022
Q4 | $3.65M | Buy |
68,890
+37,108
| +117% | +$1.96M | 0.01% | 1012 |
|
|
2022
Q3 | $1.48M | Sell |
31,782
-253,783
| -89% | -$11.8M | ﹤0.01% | 1525 |
|
|
2022
Q2 | $16.3M | Buy |
285,565
+1,967
| +0.7% | +$112K | 0.03% | 513 |
|
|
2022
Q1 | $17.4M | Buy |
283,598
+167,433
| +144% | +$10.2M | 0.02% | 543 |
|
|
2021
Q4 | $6.08M | Buy |
116,165
+38,872
| +50% | +$2.03M | 0.01% | 923 |
|
|
2021
Q3 | $2.88M | Buy |
77,293
+22,646
| +41% | +$844K | ﹤0.01% | 1281 |
|
|
2021
Q2 | $2.23M | Buy |
+54,647
| New | +$2.23M | ﹤0.01% | 1423 |
|